Key Drivers
- Strong gross margin
- Large operating loss
- Healthy liquidity
AIAI Summary
PRCT's investment case has shifted from growth-for-growth's-sake to a binary, execution-and-governance bet—product-level unit economics and a healthy cash buffer matter, but near-term returns now hinge on consistent procedure utilization/consumable pull-through, credible forward guidance, and resolution/containment of securities investigations. Actionable stance: require consecutive revenue/adjusted‑EBITDA beats with visible handpiece-per-system growth or else avoid exposure given legal and cash‑burn tail risks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong gross margin
- •Large operating loss
- •Healthy liquidity
PRCT is cash-rich with strong gross margins and very low short-term liquidity risk but is unprofitable at the operating level—sustaining large operating losses, negative cash flow and depressed returns despite modest leverage.
Price Behavior
Key Price Behavior Insights:
- •Slight downtrend
- •27.8–28 resistance
- •22.7 key support
PRCT is in a modest downtrend over the last month, trading just below its ~ $26 last-month average, with clear resistance at $27.8–$28.0 and support near $22.69 (intraperiod support around $24s), so a decisive move above $28 on strong volume would signal a reversal while a break below $22.69 warns of deeper downside.
Rapid drop on 2026-02-26–02-27 followed by sharp recovery into 2026-03-16 peak
Sentiment & News
Key News Insights:
- •Guidance miss
- •Legal probes
- •Insider/institutional buying
Procept BioRobotics missed Q4 and FY targets and reported a larger-than-expected adjusted EBITDA loss, prompting multiple investor lawsuits and heightened scrutiny in March 2026 despite some institutional and insider buying.
Expect increased share volatility and downside pressure as litigation and disclosure risk undermine investor confidence
Similar Companies in Healthcare
Other companies in the same sector with AI ratings